Marseille-Kliniken AG EUR (LSE:0QE3) - Share price - Overview

Stock Report

MK-Kliniken AG 0QE3

Last Price
-

Day Change
-|-%

As of -
- | EUR
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap-
52-Wk Range-
Yield %-
ISINDE000A1TNRR7
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201220132014
More ...
Income Statement
Revenue195.06200.11202.03
Operating Income10.9011.057.58
Net Income6.466.733.58
Basic EPS0.450.470.25
Avg. Diluted Shares Outstanding141414
Balance Sheet
Current Assets27.1027.9822.56
Non Current Assets162.39159.24158.21
Total Assets189.49187.21180.77
Current Liabilities40.5940.6736.87
Total Liabilities152.48145.68137.52
Total Equity37.0141.5443.25
Cash Flow
Operating Cash Flow6.595.8112.02
Capital Expenditure-1.73-3.68-7.43
Free Cash Flow4.862.134.59

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Marseille-Kliniken AG provides nursing care for the elderly and disabled as well as medical rehabilitation. It operates in three segments namely nursing care, rehabilitation/acute hospital treatment and services.

Sector

Healthcare

Industry

Medical Care

Stock Style

Small-Blend

Fiscal Year Ends

June

Employees

4,790
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)2.07
EPS Growth (3 year avg)-
Operating Margin % TTM3.75
Net Margin % TTM1.77
ROE TTM8.45
Debt/Equity1.02
Dividends
PreviousLatest
More ...
Declared Date25/10/1303/11/14
Ex-Div01/11/1311/11/14
Paid11/11/1311/11/14
Amnt0.120.15
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.